Year to year change in FEV1 in patients with cystic fibrosis and different mutation classes.

Abstract excerpt

In patients with cystic fibrosis, most treatments addressing the underlying basic defect are mutation or mutation class specific. These treatments are disease modifying if they lower the year to year change in lung function. We therefore calculated the current loss of lung function, measured by year to year change in forced expired volume in 1s in 11,417 patients included in the European Cystic Fibrosis Society...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Codon, Terminator
• Share to Cystic Fibrosis
• Share to Cystic Fibrosis Transmembrane Conductance Regulator